Compass Therapeutics shares rise 1.04% after-hours following Ginkgo Bioworks' strategic partnership announcement.

Compass Therapeutics, Inc. rose 1.04% in after-hours trading. The company's stock price increase may be attributed to the announcement of a new strategic partnership between Ginkgo Bioworks, Inductive Bio, and Tangible Scientific. This partnership aims to make AI-driven lab-in-the-loop drug discovery more accessible across the industry, potentially benefiting Compass Therapeutics, Inc. as it operates in the biotechnology sector.